Heteroarotinoid Compounds as Anticancer Agents
View/ Open
Date
1989-05-02Author
Berlin, Kenneth Darrell
Holt, Elizabeth M.
Ford, Warren T.
Thompson, Mark D.
Board of Regents/Oklahoma State University and the A & M Colleges
Metadata
Show full item recordAbstract
Novel heteroarotinoid compositions characterized by the formulae: ##STR1## where R is H, CH.sub.3 or C.sub.2 H.sub.5 and X is S, S O, O, NCH.sub.3, Si(CH.sub.3).sub.2, N.sup.+ (H)CH.sub.3 [Cl.sup.- ], N.sup.+ (H)CH.sub.3 [Br.sup.- ] or N.sup.+ (alkyl) CH.sub.3 [Cl.sup.- or Br.sup.-) where alkyl is CH.sub.3, C.sub.2 H.sub.5, CH.sub.2 .dbd.CHCH.sub.2 or C.sub.6 H.sub.5 CH.sub.2. Such compositions exhibit activity as anticancer agents.
Collections
- Patents [208]